文献速递消化系统肿瘤

血清miR-378与miR-21联合检测对胃癌的诊断价值

[Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2018-01-01

研究纳入胃癌87例、结直肠癌78例及健康对照83例,用RT-qPCR检测血清miR-378和miR-21水平。结果显示胃癌患者miR-378降低、miR-21升高,两者联合诊断胃癌的AUC为0.930,灵敏度92.0%,特异度87.0%,提示联合检测对胃癌有一定诊断效能。

要点

  • 胃癌患者血清miR-378表达低于健康对照,miR-21表达高于健康对照(均P<0.05)。
  • miR-378低表达与胃癌临床分期相关(P<0.05),分期越晚下降越大。
  • miR-378联合miR-21诊断胃癌AUC为0.930,灵敏度92.0%,特异度87.0%。

核心结论

  • 联合检测血清miR-378和miR-21对胃癌具有一定的诊断效能。

研究设计与样本

  • 选择中国医学科学院肿瘤医院经病理确诊的胃癌87例、结直肠癌78例及健康体检者83例。
  • 采用实时荧光定量PCR检测血清miR-378和miR-21表达水平,结果以log2转换后分析。

主要发现

  • miR-378在健康对照、胃癌和结直肠癌患者血清中的相对表达水平分别为-1.24、-3.25和-2.73。
  • miR-21在健康对照、胃癌和结直肠癌患者血清中的相对表达水平分别为0.11、2.34和2.47。
  • 胃癌和结直肠癌患者血清miR-378均低于健康对照,miR-21均高于健康对照(均P<0.05)。
  • 胃癌患者血清miR-378低表达与肿瘤临床分期相关(P<0.05),分期越晚下降程度越大。
  • miR-21在胃癌患者血清中的升高程度与临床病理特征无关(均P>0.05)。

关键数值与推荐

  • miR-378诊断胃癌的AUC为0.770,灵敏度82.0%,特异度66.0%。
  • miR-21诊断胃癌的AUC为0.900,灵敏度85.0%,特异度88.0%。
  • miR-378+miR-21诊断胃癌的AUC为0.930,灵敏度92.0%,特异度87.0%。
  • CEA+CA-199诊断胃癌的AUC为0.767。
  • CEA+CA-199+miR-378+miR-21诊断胃癌的AUC为0.946。

临床怎么用

  • 血清miR-378和miR-21联合检测可作为胃癌诊断的候选辅助指标。
  • miR-378低表达与更晚临床分期相关,或有助于提示疾病进展风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the clinical value of combined detection of serum miR-378 and miR-21 in gastric cancer (GC). Methods: Eighty-seven patients with GC and 78 patients with colorectal cancer(CRC) from National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences were selected, 83 individuals undergoing healthy physical examination were selected as the healthy controls. The levels of serum miR-378 and miR-21 were detected by quantitative real-time PCR (RT-qPCR) (result data were transformed as log2 for analysis). Results: Relative expression levels of miR-378 in the serum were -1.24, -3.25 and -2.73 in healthy controls, GC and CRC patients, respectively. Compared with the healthy controls, the levels of serum miR-378 were significantly decreased in GC and CRC patients (both P<0.05). Relative expression levels of miR-21 in the serum were 0.11, 2.34 and 2.47 in healthy controls, GC and CRC patients, respectively. Compared with the healthy controls, the levels of serum miR-21 were significantly up-regulated in GC and CRC patients (both P<0.05). Moreover, the serum level of miR-378 in GC patients was inversely associated with tumor clinical stage (P<0.05). However, the level of miR-21 showed no significant differences among patients with different clinical and pathological characteristics (all P>0.05). The area under the receiver operating characteristic curve (AUC), sensitivity and specificity of miRNA-378 to diagnose GC was 0.770, 82.0% and 66.0%, respectively, and were 0.900, 85.0%, and 88.0% of miR-21, respectively. The AUC, sensitivity and specificity of combined detection of serum miR-378 and miR-21 to diagnose GC were 0.930, 92.0% and 87.0%, respectively, while the AUC of combined detection of serum CEA and CA-199 was 0.767, the AUC of combined all of the four factors was 0.946. Conclusion: The combined detection of serum miR-378 and miR-21 have a certain effect on diagnosis of GC. 目的: 探讨血清miR-378和miR-21联合检测对胃癌的临床诊断价值。 方法: 选择中国医学科学院肿瘤医院经病理确诊的胃癌患者87例,结直肠癌患者78例,健康体检者83例,采用实时荧光定量PCR法检测血清样本中miR-378和miR-21的表达水平(以log(2)对结果进行转换)。 结果: miR-378在健康对照者、胃癌患者和结直肠癌患者血清中的相对表达水平分别为-1.24、-3.25和-2.73,miR-378在胃癌和结直肠癌患者血清中的相对表达水平明显低于健康对照者(均P<0.05)。miR-21在健康对照者、胃癌患者和结直肠癌患者血清中的相对表达水平分别为0.11、2.34和2.47,miR-21在胃癌和结直肠癌患者血清中的相对表达水平明显高于健康对照者(均P<0.05)。胃癌患者血清中miR-378的低表达与肿瘤的临床分期有关(P<0.05),分期越晚,下降程度越大;而miR-21在胃癌患者血清中的升高程度与患者的临床病理特征无关(均P>0.05)。血清miR-378诊断胃癌的曲线下面积(AUC)为0.770,灵敏度为82.0%,特异度为66.0%;miR-21诊断胃癌的AUC为0.900,灵敏度为85.0%,特异度为88.0%;miR-378+miR-21诊断胃癌的AUC为0.930,灵敏度为92.0%,特异度为87.0%。CEA+CA-199诊断胃癌的AUC为0.767,CEA+CA-199+miR-378+miR-21诊断胃癌的AUC为0.946。 结论: 联合检测血清中miR-378和miR-21的表达对胃癌具有一定的诊断效能。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Huang SK, Wang J, Li Y, et al. [Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer]. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29936770. doi:10.3760/cma.j.issn.0253-3766.2018.06.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。